Echelon Biosciences, Inc (EBI) was founded as Echelon Research Labs by two professors from the University of Utah. Their initial goal was to advance the science of lipid signaling by developing novel research reagents, assays, and ultimately technology leading to drug treatments and diagnostics for debilitating diseases.
Our goal is to be a global leader in supplying biochemical reagents, assays, and screening services to further academic research and pharmaceutical development. Echelon has always been committed to making, testing, and supporting quality reagents and providing superior service. We value integrity in business and strive to keep our focus on our customer’s needs so they can continue to do incredible research!
At Echelon, we strive to leverage our expertise in custom synthesis and assay development to create only the best reagents for biological and drug discovery research. Our aim is to simplify the process of basic research and keep scientists moving forward.